IP Library › Granted Patent US 7,179,482
Granted Patent B2
US 7,179,482 · App. 10/853,401 · Granted Feb 20, 2007

Implant device with a retinoid for improved biocompatibility

Assignee: Allergan, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,179,482
App. No.
10/853,401
Granted
Feb 20, 2007
Kind
B2
Abstract

An implant device is provided which incorporates a retinoid for improving the biocompatibility of the device in tissue. The device may be bioerodible for the purpose of systemically or locally releasing a therapeutic agent in tissue or it may be a permanent implant which includes a surface treated with a retinoid for increasing the biocompatibility thereof.

Claims (3)

1. In a device for implant into tissue an improvement comprising a retinoid for improving biocompatibiity of the device with the tissue and wherein the device comprises a surgically implantable hard tissue replacement prosthesis.

2. The improvement according to claim 1 wherein said retinoid is coated on the device.

3. The improvement according to claim 1 wherein said retinoid is bonded to the device.

Continuity (7)
Continuation 1039617900 · Mar 24, 2003
Continuation 0998221900 · Oct 17, 2001
Continuation 0958748500 · Jun 5, 2000
Continuation In Part 0935607400 · Jul 16, 1999
Continuation 0915099000 · Sep 10, 1998
Continuation 0890809400 · Aug 11, 1997
Related Publication 20040219187A1 · Nov 4, 2004